4.7 Review

Plasmonic nanoprobes for intracellular sensing and imaging

期刊

ANALYTICAL AND BIOANALYTICAL CHEMISTRY
卷 405, 期 19, 页码 6165-6180

出版社

SPRINGER HEIDELBERG
DOI: 10.1007/s00216-013-6975-1

关键词

Plasmonic; Nanoparticle; Surface-enhanced Raman scattering; Two-photon photoluminescence; Biosensing; Cellular imaging

向作者/读者索取更多资源

Recent advances in integrating nanotechnology and optical microscopy offer great potential in intracellular applications with improved molecular information and higher resolution. Continuous efforts in designing nanoparticles with strong and tunable plasmon resonance have led to new developments in biosensing and bioimaging, using surface-enhanced Raman scattering and two-photon photoluminescence. We provide an overview of the nanoprobe design updates, such as controlling the nanoparticle shape for optimal plasmon peak position; optical sensing and imaging strategies for intracellular nanoparticle detection; and addressing practical challenges in cellular applications of nanoprobes, including the use of targeting agents and control of nanoparticle aggregation.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Nanoscience & Nanotechnology

Non-invasive sensitive brain tumor detection using dual-modality bioimaging nanoprobe

Yang Liu, Austin B. Carpenter, Christopher J. Pirozzi, Hsiangkuo Yuan, Matthew S. Waitkus, Zhengyuan Zhou, Landon Hansen, Michelle Seywald, Ren Odion, Paula K. Greer, Thomas Hawk, Bennett B. Chin, Ganesan Vaidyanathan, Michael R. Zalutsky, Hai Yan, Tuan Vo-Dinh

NANOTECHNOLOGY (2019)

Review Clinical Neurology

Non-invasive vagus nerve stimulation for primary headache: A clinical update

Stephen D. Silberstein, Hsiangkuo Yuan, Umer Najib, Jessica Ailani, Andreia Lopes de Morais, Paul G. Mathew, Eric Liebler, Cristina Tassorelli, Hans-Christoph Diener

CEPHALALGIA (2020)

Article Clinical Neurology

Guidelines of the International Headache Society for clinical trials with neuromodulation devices for the treatment of migraine

Cristina Tassorelli, Hans-Christoph Diener, Stephen D. Silberstein, David W. Dodick, Peter J. Goadsby, Rigmor H. Jensen, Delphine Magis, Patricia Pozo-Rosich, Hsiangkuo Yuan, Daniele Martinelli, Thomas van den Hoek, Marie Deen, Messoud Ashina, Gisela M. Terwindt

Summary: The International Headache Society's Clinical Trials Committee has provided recommendations for optimizing the design and conduct of controlled trials of neuromodulation devices for the acute and/or preventive treatment of migraine. This includes defining key terms, providing recommendations for assessment in different age groups, outlining ethical and administrative responsibilities, and creating a bibliography of previous research in this area. Adopting these recommendations will improve the quality of evidence regarding the use of neuromodulation devices in migraine treatment.

CEPHALALGIA (2021)

Review Clinical Neurology

Update of Neuromodulation in Chronic Migraine

Hsiangkuo Yuan, Tzu-Ying Chuang

Summary: Neuromodulation devices have become an attractive alternative to traditional pharmacotherapy for migraine, especially for patients intolerant to medication or who prefer non-pharmacological options. Studies on the efficacy of these devices in chronic migraine are limited, but show promising results, although more well-designed research is needed for FDA clearance and insurance coverage.

CURRENT PAIN AND HEADACHE REPORTS (2021)

Article Clinical Neurology

Intravenous ibuprofen for acute treatment of migraine: A double-blind, randomized, placebo-controlled pilot study

Hsiangkuo Yuan, John G. Curran, Scott W. Keith, Mary M. Hopkins, Stephen D. Silberstein

Summary: The study evaluated the efficacy and safety of IV ibuprofen for acute migraine treatment. While the primary endpoint was not met, there was significant pain relief within 2 hours post-treatment with IV ibuprofen compared to placebo. Adverse events were minimal, suggesting that IV ibuprofen may be a safe and effective option for acute migraine treatment. Further studies with larger sample sizes are needed for confirmation.

HEADACHE (2021)

Review Clinical Neurology

Care Gaps and Recommendations in Vestibular Migraine: An Expert Panel Summit

Monica P. Mallampalli, Habib G. Rizk, Amir Kheradmand, Shin C. Beh, Mehdi Abouzari, Alaina M. Bassett, James Buskirk, Claire E. J. Ceriani, Matthew G. Crowson, Hamid Djalilian, Joel A. Goebel, Jeffery J. Kuhn, Anne E. Luebke, Marco Mandala, Magdalena Nowaczewska, Nicole Spare, Roberto Teggi, Maurizio Versino, Hsiangkuo Yuan, Ashley Zaleski-King, Michael Teixido, Frederick Godley

Summary: Vestibular migraine is increasingly recognized as a pathological cause of vestibular disorders, yet it remains underdiagnosed. The pathophysiology of this disorder is still unclear. A multidisciplinary expert workshop identified seven current care gaps that need to be resolved, including a better understanding of symptoms and phenotypes, a lack of diagnostic markers, a better understanding of pathophysiological mechanisms, as well as the need for clear recommendations and outcome measures. Recommendations were made to address these gaps, such as establishing a global registry and conducting trials to validate current treatments.

FRONTIERS IN NEUROLOGY (2022)

Review Oncology

Calcitonin Gene-Related Peptide (CGRP)-Targeted Monoclonal Antibodies and Antagonists in Migraine: Current Evidence and Rationale

Fred Cohen, Hsiangkuo Yuan, Stephen D. Silberstein

Summary: Calcitonin gene-related peptide (CGRP) is believed to be involved in the pathogenesis of migraine, and there are two classes of therapeutic agents targeting CGRP: CGRP-targeted monoclonal antibodies and small-molecule antagonists. Multiple clinical studies have shown the efficacy and tolerability of these treatments.

BIODRUGS (2022)

Article Clinical Neurology

Most bothersome symptoms in patients with migraine: A hospital-based study in Taiwan

Yi-Hsien Tu, Yen-Feng Wang, Hsiangkuo Yuan, Shih-Pin Chen, Yi-Shiang Tzeng, Wei-Ta Chen, Kuan-Lin Lai, Yu-Hsiang Ling, Shuu-Jiun Wang

Summary: This study investigated the distribution, clinical associations, and treatment responses for the most bothersome symptoms of migraine in a large sample of patients in Taiwan. Nausea was found to be the most common most bothersome symptom, followed by phonophobia and photophobia. The response rates to previous acute treatments for different most bothersome symptoms were similar.

HEADACHE (2022)

Review Clinical Neurology

The Arrival of Anti-CGRP Monoclonal Antibodies in Migraine

Fred Cohen, Hsiangkuo Yuan, E. M. G. DePoy, Stephen D. Silberstein

Summary: Remarkable advancements have been made in the field of migraine research and treatment, particularly with the discovery of CGRP functional blocking monoclonal antibodies (mAbs) as an effective preventive therapy for both chronic and episodic migraine. These mAbs offer advantages such as high affinity and selectivity, long-circulating plasma half-lives, and limited risk for side effects and drug-drug interactions. However, long-term safety and use during pregnancy should be further studied.

NEUROTHERAPEUTICS (2022)

Review Health Care Sciences & Services

Role of Atogepant in the Treatment of Episodic Migraines: Clinical Perspectives and Considerations

Fred Cohen, Hsiangkuo Yuan

Summary: Advances in molecular biology and neuroscience have led to the discovery of CGRP and its role in migraine. Gepants, including atogepant, are oral medications that inhibit CGRP receptors to prevent migraine attacks and neurogenic inflammation.

THERAPEUTICS AND CLINICAL RISK MANAGEMENT (2022)

Review Clinical Neurology

Short-lasting unilateral neuralgiform headache attacks (SUNCT/SUNA): a narrative review of interventional therapies

Rupert D. Smit, Nikolaos Mouchtouris, KiChang Kang, Maikerly Reyes, Anish Sathe, Sarah Collopy, Giyarpuram Prashant, Hsiangkuo Yuan, James J. Evans

Summary: This literature review examines the evidence for interventional therapies in medically intractable SUNCT/SUNA, including occipital nerve stimulation, pulsed radiofrequency, stereotactic radiosurgery, and microvascular decompression. The review finds promising outcomes with these treatments, but emphasizes the need for further research.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2023)

Article Anesthesiology

Real-world study of intranasal ketamine for use in patients with refractory chronic migraine: a retrospective analysis

Hsiangkuo Yuan, Aniket Natekar, Jade Park, Clinton G. Lauritsen, Eugene R. Viscusi, Michael J. Marmura

Summary: This retrospective study assessed the prevalence, harms, and effectiveness of prescription drug misuse and "lean" (cough syrup) in patients with treatment-resistant headaches. The results showed that both prescription drug misuse and "lean" were common among patients with treatment-resistant headaches, but they were not effective in treating headaches.

REGIONAL ANESTHESIA AND PAIN MEDICINE (2023)

Article Anesthesiology

Debunking myths in headache diagnosis for the pain practitioner

Hsiangkuo Yuan, Samantha Strutner, Clara Yuh, Suwarna Anand, Gaurav Chauhan, Anand Prem, Shalini Shah, Nathaniel M. Schuster

Summary: With headache being a common complaint, accurately diagnosing and treating specific headache disorders requires understanding and differentiating various headache characteristics. This article discusses several myths about common headache disorders and provides a discussion based on the International Classification of Headache Disorders and the latest studies. Understanding the intricacies of headache diagnoses helps providers provide better care for patients.

REGIONAL ANESTHESIA AND PAIN MEDICINE (2023)

Article Chemistry, Analytical

3D-printed phantoms for characterizing SERS nanoparticle detectability in turbid media

Andrew M. Fales, Pietro Strobbia, Tuan Vo-Dinh, Ilko K. Ilev, T. Joshua Pfefer

ANALYST (2020)

暂无数据